BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) shares fell 4.3% during mid-day trading on Friday . The stock traded as low as $0.44 and last traded at $0.47. 681,387 shares changed hands during trading, an increase of 545% from the average session volume of 105,573 shares. The stock had previously closed at $0.49.
Wall Street Analyst Weigh In
Separately, HC Wainwright dropped their target price on shares of BiomX from $21.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, May 16th.
View Our Latest Report on BiomX
BiomX Trading Down 4.3%
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Recommended Stories
- Five stocks we like better than BiomX
- Why Are These Companies Considered Blue Chips?
- Five Below Pops on Strong Earnings, But Rally May Stall
- How to Read Stock Charts for Beginners
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
